• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants - Product Image

Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants

  • Published: April 2013
  • Region: Global, Asia
  • 137 Pages
  • GBI Research

FEATURED COMPANIES

  • CSL Biotherapies
  • Novartis Vaccines
  • Sanofi Pasteur
  • MORE

GBI Research, the leading business intelligence provider has released its latest research “Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants” which essentially provides insights into the seasonal influenza vaccine sales forecasts for the Asia-Pacific Region until 2018. The report also delves deep into vaccination patterns for seasonal influenza in the Asia-Pacific Region. Further, the geographical distribution of seasonal influenza vaccines across Japan, Australia, New Zealand, China, Taiwan, Philippines, Hong Kong, Malaysia, India and Singapore are also provided in the report. The report offers a clear view of the regulatory landscape in the Asia-Pacific countries. The report also reveals the seasonal influenza vaccine R&D pipeline and offers profiles of promising vaccines. The report explores the competitive landscape including profiles for top companies. Finally, the key trend analysis on mergers and acquisitions, and licensing agreements involving seasonal influenza vaccines is also presented.

Treatment READ MORE >

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction

3 Seasonal Influenza Vaccine Market in Asia-Pacific – Market Overview
3.1 Market Characterization and Forecasts
3.2 Revenue by Geographical Segmentation

4 Seasonal Influenza Vaccine Market in Asia-Pacific – Australia
4.1 Registration Process and Regulations
4.2 Market Characterization and Forecasts
4.3 Cost of Vaccination
4.4 Vaccination Pattern
4.4.1 Population
4.4.2 Vaccinated Population Contribution
4.4.3 Vaccination Coverage
4.4.4 Number of Doses per Person
4.4.5 Total Number of Doses
4.4.6 Dose Contribution
4.5 Drivers and Barriers
4.5.1 Drivers
4.5.2 Restraints

5 Seasonal Influenza Vaccine Market in Asia-Pacific – China
5.1 Registration Process and Regulations
5.2 Market Characterization and Forecasts
5.3 Cost of Vaccination
5.4 Vaccination Pattern
5.4.1 Population
5.4.2 Vaccinated Population Contribution
5.4.3 Vaccination Coverage
5.4.4 Number of Doses per Person
5.4.5 Total Number of Doses
5.4.6 Dose Contribution
5.5 Competitive Landscape
5.6 Drivers and Barriers
5.6.1 Drivers
5.6.2 Barriers

6 Seasonal Influenza Vaccine Market in Asia-Pacific – Hong Kong
6.1 Registration Process and Regulations
6.2 Market Characterization and Forecasts
6.3 Cost of Vaccination
6.4 Vaccination Pattern
6.4.1 Population
6.4.2 Vaccinated Population Contribution
6.4.3 Vaccination Coverage
6.4.4 Number of Doses per Person
6.4.5 Total Number of Doses
6.4.6 Dose Contribution
6.5 Competitive Landscape
6.6 Drivers and Barriers
6.6.1 Drivers
6.6.2 Restraints

7 Seasonal Influenza Vaccine Market in Asia-Pacific – India
7.1 Registration Process and Regulations
7.2 Market Characterization and Forecasts
7.3 Cost of Vaccination
7.4 Drivers and Barriers
7.4.1 Drivers
7.4.2 Barriers

8 Seasonal Influenza Vaccine Market in Asia-Pacific – Japan
8.1 Registration Process and Regulations
8.2 Market Characterization and Forecasts
8.3 Cost of Vaccination
8.4 Vaccinated Population
8.4.1 Population
8.4.2 Vaccinated Population Contribution
8.4.3 Vaccination Coverage
8.5 Drivers and Restraints
8.5.1 Drivers
8.5.2 Barriers

9 Seasonal Influenza Vaccine Market in Asia-Pacific – Malaysia
9.1 Registration Process and Regulations
9.2 Market Characterization and Forecasts
9.3 Cost of Vaccination
9.4 Vaccination Pattern
9.4.1 Population
9.4.2 Vaccinated Population Contribution
9.4.3 Vaccination Coverage
9.4.4 Number of Doses per Person
9.4.5 Total Number of Doses
9.4.6 Dose Contribution
9.5 Competitive Landscape
9.6 Drivers and Barriers
9.6.1 Drivers
9.6.2 Barriers

10 Seasonal Influenza Vaccine Market in Asia-Pacific – New Zealand
10.1 Registration Process and Regulations
10.2 Market Characterization and Forecasts
10.3 Cost of Vaccination
10.4 Vaccination Pattern
10.4.1 Population
10.4.2 Vaccinated Population Contribution
10.4.3 Vaccination Coverage
10.4.4 Number of Doses per Person
10.4.5 Total Number of Doses
10.4.6 Dose Contribution
10.5 Competitive Landscape
10.6 Drivers and Barriers
10.6.1 Drivers
10.6.2 Barriers

11 Seasonal Influenza Vaccine Market in Asia-Pacific – Philippines
11.1 Registration Process and Regulations
11.2 Market Characterization and Forecasts
11.3 Cost of Vaccination
11.4 Vaccination Pattern
11.4.1 Population
11.4.2 Vaccinated Population Contribution
11.4.3 Vaccination Coverage
11.4.4 Number of Doses per Person
11.4.5 Total Number of Doses
11.4.6 Dose Contribution
11.5 Competitive Landscape
11.6 Drivers and Barriers
11.6.1 Drivers
11.6.2 Restraints

12 Seasonal Influenza Vaccine Market in Asia-Pacific – Singapore
12.1 Registration Process and Regulations
12.2 Market Characterization and Forecasts
12.3 Cost of Vaccination
12.4 Vaccination Pattern
12.4.1 Population
12.4.2 Vaccinated Population Contribution
12.4.3 Vaccination Coverage
12.4.4 Number of Doses per Person
12.4.5 Total Number of Doses
12.4.6 Dose Contribution
12.5 Competitive Landscape
12.6 Drivers and Barriers
12.6.1 Drivers
12.6.2 Barriers

13 Seasonal Influenza Vaccine Market in Asia-Pacific – Taiwan
13.1 Registration Process and Regulations
13.2 Market Characterization and Forecasts
13.3 Cost of Vaccination
13.4 Vaccination Pattern
13.4.1 Population
13.4.2 Vaccinated Population Contribution
13.4.3 Vaccination Coverage
13.4.4 Number of Doses per Person
13.4.5 Total Number of Doses
13.4.6 Dose Contribution
13.5 Competitive Landscape
13.6 Drivers and Barriers
13.6.1 Drivers
13.6.2 Restraints

14 Seasonal Influenza Vaccine Market in Asia-Pacific - Pipeline Analysis
14.1 Pipeline Analysis by Phase
14.2 Product Profiles of Promising Molecules
14.2.1 Optaflu
14.2.2 GSK2186877A
14.2.3 Intanza/Flu-ID
14.2.4 Fluad Pediatric
14.2.5 FluBlok
14.3 Product Profiles of Marketed Products
14.3.1 Fluarix
14.3.2 Vaxigrip
14.3.3 Influvac
14.3.4 Fluvax
14.3.5 Agrippal

15 Seasonal Influenza Vaccine Market in Asia-Pacific – Competitive Landscape
15.1 Sanofi Pasteur
15.2 GlaxoSmithKline Biologicals
15.3 Abbott Laboratories (Solvay Pharmaceuticals)
15.4 CSL Biotherapies
15.5 Novartis Vaccines
15.6 Crucell N.V. (Berna Biotech)

16 Seasonal Influenza Vaccine Market in Asia-Pacific – Strategic Consolidations
16.1 Overview
16.2 Major Merger and Acquisition Deals, 2007–2012
16.2.1 AstraZeneca Acquires Medimmune
16.2.2 Sanofi-Aventis (now Sanofi) Acquires Acambis
16.2.3 Mymetics Acquires Virosome Biologicals
16.2.4 Simcere Pharmaceutical Acquires a Majority Stake in Jiangsu Yanshen Biological Technology Stock
16.2.5 Novartis Completes Acquisition of 85% Stake in Zhejiang Tianyuan
16.2.6 Abbott Laboratories Acquires Solvay Pharmaceuticals
16.2.7 Nutri Pharma Acquires a Majority Stake in Bionor Immuno
16.2.8 Johnson & Johnson Acquires Crucell
16.2.9 GlaxoSmithKline to Acquire Remaining Interest in Shenzhen GSK-Neptunus Biologicals
16.3 M&A Deals by Geography
16.4 Major Licensing Agreements, 2007–2012
16.4.1 Crucell Enters into License Agreement with Adimmune Corporation
16.4.2 MedImmune Enters into Licensing Agreement with Sanofi Pasteur
16.4.3 Vivalis Enters into Licensing Agreement with GlaxoSmithKline
16.4.4 Vivalis Enters into Licensing Agreement with Nobilon International
16.4.5 MedImmune Enters into Licensing Agreement with GlaxoSmithKline
16.4.6 Hemispherx Biopharma Enters into Licensing Agreement with Biken
16.4.7 MedImmune Enters into Licensing Agreement with Biken
16.4.8 MedImmune Enters into Licensing Agreement with Omninvest
16.4.9 OPKO Health Enters into Licensing Agreement with Academia Sinica
16.4.10 Altravax Enters into Licensing Agreement with Maxygen
16.4.11 Protein Sciences Expands its Licensing Agreement with UMN Pharma for FluBlok and PanBlok
16.4.12 NasVax Extends its Research Agreement with Novartis
16.4.13 iBio Enters into Licensing Agreement with G-Con
16.5 Licensing Deals by Geography

17 Seasonal Influenza Vaccine Market in Asia-Pacific – Appendix
17.1 Market Definitions
17.2 Abbreviations
17.3 Bibliography
17.4 Research Methodology
17.4.1 Coverage
17.4.2 Secondary Research
17.4.3 Primary Research
17.5 Therapeutic Landscape
17.5.2 Market Size by Geography
17.6 Geographical Landscape
17.7 Pipeline Analysis
17.8 Competitive Landscape
17.8.1 Expert Panel Validation
17.9 Contact Us
17.10 Disclaimer

1.1 List of Tables

Table 1: Seasonal Influenza Vaccine Market, APAC Region, Revenue Forecast ($bn), 2011–2018
Table 2: Seasonal Influenza Vaccine Market, APAC Region, Revenue Forecast by Geography ($m), 2011–2018
Table 3: Seasonal Influenza Vaccine Market, Australia, Revenue Forecast ($m), 2011–2018
Table 4: Seasonal Influenza Vaccine Market, Australia, Vaccination Cost Forecast ($), 2011–2018
Table 5: Seasonal Influenza Vaccine Market, Australia, Population Forecast by Age Group (million), 2011–2018
Table 6: Seasonal Influenza Vaccine Market, Australia, Vaccinated Population Forecast by Age Group (%), 2011–2018
Table 7: Seasonal Influenza Vaccine Market, Australia, Vaccination Coverage Forecast by Age Group (million), 2011–2018
Table 8: Seasonal Influenza Vaccine Market, Australia, Number of Doses Forecast by Age Group (million), 2011–2018
Table 9: Seasonal Influenza Vaccine Market, China, Revenue Forecast ($m), 2011–2018
Table 10: Seasonal Influenza Vaccine Market, China, Vaccination Cost Forecast ($), 2011–2018
Table 11: Seasonal Influenza Vaccine Market, China, Population Forecast by Age Group (million), 2011–2018
Table 12: Seasonal Influenza Vaccine Market, China, Vaccinated Population Forecast (%), 2011–2018
Table 13: Seasonal Influenza Vaccine Market, China, Vaccination Coverage Forecast (million), 2011–2018
Table 14: Seasonal Influenza Vaccine Market, China, Number of Doses Forecast (million), 2011–2018
Table 15: Seasonal Influenza Vaccine Market, Hong Kong, Revenue Forecast ($m), 2011–2018
Table 16: Seasonal Influenza Vaccine Market, Hong Kong, Vaccination Cost Forecast ($), 2011–2018
Table 17: Seasonal Influenza Vaccine Market, Hong Kong, Population Forecast by Age Group, (million), 2011–2018
Table 18: Seasonal Influenza Vaccine Market, Hong Kong, Vaccinated Population Forecast by Age Group (%), 2011–2018
Table 19: Seasonal Influenza Vaccine Market, Hong Kong, Vaccination Coverage Forecast (‘000), 2011–2018
Table 20: Seasonal Influenza Vaccine Market, Hong Kong, Number of Doses Forecast by Age Group (‘000), 2011–2018
Table 21: Seasonal Influenza Vaccine Market, India, Revenue Forecast ($m), 2011–2018
Table 22: Seasonal Influenza Vaccine Market, India, Vaccination Cost Forecast ($), 2011–2018
Table 23: Seasonal Influenza Vaccine Market, Japan, Revenue Forecast ($m), 2011–2018
Table 24: Seasonal Influenza Vaccine Market, Japan, Vaccine Cost ($), 2011–2018
Table 25: Seasonal Influenza Vaccine Market, Japan, Population Forecast by Age Group (million), 2011–2018
Table 26: Seasonal Influenza Vaccine Market, Japan, Vaccination Coverage Forecast by Age Group (%), 2011–2018
Table 27: Seasonal Influenza Vaccine Market, Japan, Overall Vaccination Coverage (million), 2011–2018
Table 28: Seasonal Influenza Vaccine Market, Japan, Vaccination Coverage by Age Group (million), 2011–2018
Table 29: Seasonal Influenza Vaccine Market, Japan, Number of Doses Forecast (million), 2011–2018
Table 30: Seasonal Influenza Vaccine Market, Japan, Number of Doses Forecast by Age Group (million), 2011–2018
Table 31: Seasonal Influenza Vaccine Market, Malaysia, Revenue Forecast ($m), 2011–2018
Table 32: Seasonal Influenza Vaccine Market, Malaysia, Vaccination Cost Forecast ($), 2011–2018
Table 33: Seasonal Influenza Vaccine Market, Malaysia, Population Forecast by Age Group (million), 2011–2018
Table 34: Seasonal Influenza Vaccine Market, Malaysia, Vaccinated Population Forecast by Age Group (%), 2011–2018
Table 35: Seasonal Influenza Vaccine Market, Malaysia, Vaccination Coverage Forecast by Age Group (‘000), 2011–2018
Table 36: Seasonal Influenza Vaccine Market, Malaysia, Number of Doses Forecast by Age Group (‘000), 2011–2018
Table 37: Seasonal Influenza Vaccine Market, New Zealand, Revenue Forecast ($m), 2011–2018
Table 38: Seasonal Influenza Vaccine Market, New Zealand, Vaccination Cost Forecast (%), 2011–2018
Table 39: Seasonal Influenza Vaccine Market, New Zealand, Population by Age Group Forecast (million), 2011–2018
Table 40: Seasonal Influenza Vaccine Market, New Zealand, Vaccinated Population Forecast (%), 2011–2018
Table 41: Seasonal Influenza Vaccine Market, New Zealand, Vaccination Coverage Forecast (‘000), 2011–2018
Table 42: Seasonal Influenza Vaccine Market, New Zealand, Number of Doses Forecasts (‘000), 2011–2018
Table 43: Seasonal Influenza Vaccine Market, Philippines, Revenue Forecast ($m), 2011–2018
Table 44: Seasonal Influenza Vaccine Market, Philippines, Vaccination Cost Forecast ($), 2011–2018
Table 45: Seasonal Influenza Vaccine Market, Philippines, Population Forecast (million), 2011–2018
Table 46: Seasonal Influenza Vaccine Market, Philippines, Vaccinated Population Forecast (%), 2011–2018
Table 47: Seasonal Influenza Vaccine Market, Philippines, Vaccination Coverage Forecast (million), 2011–2018
Table 48: Seasonal Influenza Vaccine Market, Philippines, Number of Doses Forecast (million), 2011–2018
Table 49: Seasonal Influenza Vaccine Market, Singapore, Revenue Forecast ($m), 2011–2018
Table 50: Seasonal Influenza Vaccine Market, Singapore, Vaccination Cost Forecast ($), 2011–2018
Table 51: Seasonal Influenza Vaccine Market, Singapore, Population Forecast by Age Group (million), 2011–2018
Table 52: Seasonal Influenza Vaccine Market, Singapore, Vaccinated Population Forecast by Age Group (%), 2011–2018
Table 53: Seasonal Influenza Vaccine Market, Singapore, Vaccination Coverage Forecast (‘000), 2011–2018
Table 54: Seasonal Influenza Vaccine Market, Singapore, Number of Doses Forecast by Age Group (‘000), 2011–2018
Table 55: Seasonal Influenza Vaccine Market, Taiwan, Revenue Forecast ($m), 2011–2018
Table 56: Seasonal Influenza Vaccine Market, Taiwan, Vaccination Cost Forecast ($), 2011–2018
Table 57: Seasonal Influenza Vaccine Market, Taiwan, Population Forecast by Age Group (million), 2011–2018
Table 58: Seasonal Influenza Vaccine Market, Taiwan, Vaccinated Population Forecast by Age Group (%), 2011–2018
Table 59: Seasonal Influenza Vaccine Market, Taiwan, Vaccination Coverage Forecast by Age Group (million), 2011–2018
Table 60: Seasonal Influenza Vaccine Market, Taiwan, Number of Doses Forecast by Age Group (million), 2011–2018
Table 61: Seasonal Influenza Vaccine Market, APAC Region, Pipeline, Filed, 2012
Table 62: Seasonal Influenza Vaccine Market, APAC Region, Pipeline, Phase III, 2012
Table 63: Seasonal Influenza Vaccine Market, APAC Region, Pipeline, Phase II, 2012
Table 64: Seasonal Influenza Vaccine Market, APAC Region, Pipeline, Phase I, 2012
Table 65: Seasonal Influenza Vaccine Market, APAC Region, Pipeline, Preclinical, 2012
Table 66: Seasonal Influenza Vaccine Market, APAC Region, Pipeline, Discovery Phase, 2012
Table 67: Seasonal Influenza Vaccine Market, APAC Region, Most Promising Vaccines in Clinical Development, 2012
Table 68: Seasonal Influenza Vaccine Market, APAC Region, Major M&A Deals, 2007–2012

1.2 List of Figures

Figure 1: Seasonal Influenza Vaccine Market, APAC Region, Revenue Forecast ($m), 2011–2018
Figure 2: Seasonal Influenza Vaccine Market, APAC Region, Revenue Forecast by Geography ($bn), 2011–2018
Figure 3: Seasonal Influenza Vaccine Market, Australia, Regulatory Authorities, 2012
Figure 4: Seasonal Influenza Vaccine Market, Australia, Drug Approval Process, 2011
Figure 5: Seasonal Influenza Vaccine Market, Australia, Revenue Forecast ($m), 2011–2018
Figure 6: Seasonal Influenza Vaccine Market, Australia, Vaccination Cost Forecast ($), 2011–2018
Figure 7: Seasonal Influenza Vaccine Market, Australia, Population Forecast by Age Group (million), 2011–2018
Figure 8: Seasonal Influenza Vaccine Market, Australia, Vaccinated Population Forecast by Age Group (%), 2011–2018
Figure 9: Seasonal Influenza Vaccine Market, Australia, Number of Doses Forecast by Age Group (million), 2011–2018
Figure 10: Seasonal Influenza Vaccine Market, Australia, Drivers and Barriers, 2012
Figure 11: Seasonal Influenza Vaccine Market, China, Regulatory Authorities, 2011
Figure 12: Seasonal Influenza Vaccine Market, China, New Drug Registration Process, 2011
Figure 13: Seasonal Influenza Vaccine Market, China, Revenue Forecast ($m), 2011–2018
Figure 14: Seasonal Influenza Vaccine Market, China, Vaccination Cost Forecast ($), 2011–2018
Figure 15: Seasonal Influenza Vaccine Market, China, Population Forecast by Age Group (million), 2011–2018
Figure 16: Seasonal Influenza Vaccine Market, China, Vaccinated Population Forecast (%), 2011–2018
Figure 17: Seasonal Influenza Vaccine Market, China, Number of Doses Forecast (million), 2011–2018
Figure 18: Seasonal Influenza Vaccine Market, China, Drivers and Barriers, 2012
Figure 19: Seasonal Influenza Vaccine Market, Hong Kong, Regulatory Authorities, 2011
Figure 20: Seasonal Influenza Vaccine Market, Hong Kong, Drug Approval Process, 2011
Figure 21: Seasonal Influenza Vaccine Market, Hong Kong, Revenue Forecast ($m), 2011–2018
Figure 22: Seasonal Influenza Vaccine Market, Hong Kong, Vaccination Cost Forecast ($), 2011–2018
Figure 23: Seasonal Influenza Vaccine Market, Hong Kong, Population Forecast by Age Group (million), 2011–2018
Figure 24: Seasonal Influenza Vaccine Market, Hong Kong, Vaccinated Population Forecast by Age Group (%), 2011–2018
Figure 25: Seasonal Influenza Vaccine Market, Hong Kong, Number of Doses Forecast by Age Group (‘000), 2011–2018
Figure 26: Seasonal Influenza Vaccine Market, Hong Kong, Market Share by Company (%), 2012
Figure 27: Seasonal Influenza Vaccine Market, Hong Kong, Drivers and Barriers, 2012
Figure 28: Seasonal Influenza Vaccine Market, India, Regulatory Authority, 2011
Figure 29: Seasonal Influenza Vaccine Market, India, Common Technical Document Application, 2011
Figure 30: Seasonal Influenza Vaccine Market, India, Drug Approval Process, 2011
Figure 31: Seasonal Influenza Vaccine Market, India, Revenue Forecast ($m), 2011–2018
Figure 32: Seasonal Influenza Vaccine Market, India, Vaccination Cost Forecast ($), 2011–2018
Figure 33: Seasonal Influenza Vaccine Market, India, Drivers and Barriers, 2012
Figure 34: Seasonal Influenza Vaccine Market, Japan, Regulatory Authorities, 2012
Figure 35: Seasonal Influenza Vaccine Market, Japan, Drug Approval Process, 2012
Figure 36: Seasonal Influenza Vaccine Market, Japan, Revenue Forecast ($m), 2011–2018
Figure 37: Seasonal Influenza Vaccine Market, Japan, Population Forecast by Age Group (million), 2011–2018
Figure 38: Seasonal Influenza Vaccine Market, Japan, Vaccination Coverage Forecast by Age Group (%), 2011–2018
Figure 39: Seasonal Influenza Vaccine Market, Japan, Number of Doses Forecast by Age Group (million), 2011–2018
Figure 40: Seasonal Influenza Vaccine Market, Japan, Drivers and Barriers, 2012
Figure 41: Seasonal Influenza Vaccine Market, Malaysia, Regulatory Authorities, 2011
Figure 42: Seasonal Influenza Vaccine Market, Malaysia, Drug Approval Process, 2011
Figure 43: Seasonal Influenza Vaccine Market, Malaysia, Revenue Forecast ($m), 2011–2018
Figure 44: Seasonal Influenza Vaccine Market, Malaysia, Vaccination Cost Forecast ($), 2011–2018
Figure 45: Seasonal Influenza Vaccine Market, Malaysia, Population Forecast by Age Group (million), 2011–2018
Figure 46: Seasonal Influenza Vaccine Market, Malaysia, Vaccinated Population Forecast by Age Group (%), 2011–2018
Figure 47: Seasonal Influenza Vaccine Market, Malaysia, Number of Doses Forecast by Age Group (‘000), 2011–2018
Figure 48: Seasonal Influenza Vaccine Market, Malaysia, Market Share by Company (%), 2012
Figure 49: Seasonal Influenza Vaccine Market, Malaysia, Drivers and Barriers, 2012
Figure 50: Seasonal Influenza Vaccine Market, New Zealand, Regulatory Authorities, 2011
Figure 51: Seasonal Influenza Vaccine Market, New Zealand, Drug Approval Process, 2011
Figure 52: Seasonal Influenza Vaccine Market, New Zealand, Revenue Forecast ($m), 2011–2018
Figure 53: Seasonal Influenza Vaccine Market, New Zealand, Vaccination Cost Forecast ($), 2011–2018
Figure 54: Seasonal Influenza Vaccine Market, New Zealand, Population by Age Group Forecast (million), 2011–2018
Figure 55: Seasonal Influenza Vaccine Market, New Zealand, Vaccinated Population Forecast (%), 2011–2018
Figure 56: Seasonal Influenza Vaccine Market, New Zealand, Number of Doses Forecast (‘000), 2011–2018
Figure 57: Seasonal Influenza Vaccine Market, New Zealand, Market Share by Company (%), 2012
Figure 58: Seasonal Influenza Vaccine Market, New Zealand, Drivers and Barriers, 2012
Figure 59: Seasonal Influenza Vaccine Market, Philippines, Regulatory Authorities, 2011
Figure 60: Seasonal Influenza Vaccine Market, Philippines, Drug Approval Process, 2011
Figure 61: Seasonal Influenza Vaccine Market, Philippines, Revenue Forecast ($m), 2011–2018
Figure 62: Seasonal Influenza Vaccine Market, Philippines, Vaccination Cost Forecast ($m), 2011–2018
Figure 63: Seasonal Influenza Vaccine Market, Philippines, Population Forecast (million), 2011–2018
Figure 64: Seasonal Influenza Vaccine Market, Philippines, Vaccinated Population Forecast (%), 2011–2018
Figure 65: Seasonal Influenza Vaccine Market, Philippines, Number of Doses Forecast (million), 2011–2018
Figure 66: Seasonal Influenza Vaccine Market, Philippines, Market Share by Company (%), 2012
Figure 67: Seasonal Influenza Vaccine Market, Philippines, Drivers and Barriers, 2012
Figure 68: Seasonal Influenza Vaccine Market, Singapore, Regulatory Authorities, 2011
Figure 69: Seasonal Influenza Vaccine Market, Singapore, Drug Approval Process, 2011
Figure 70: Seasonal Influenza Vaccine Market, Singapore, Revenue Forecast ($m), 2011–2018
Figure 71: Seasonal Influenza Vaccine Market, Singapore, Vaccination Cost Forecast ($), 2011–2018
Figure 72: Seasonal Influenza Vaccine Market, Singapore, Population Forecast by Age Group (million), 2011–2018
Figure 73: Seasonal Influenza Vaccine Market, Singapore, Vaccinated Population Forecast by Age Group (%), 2011–2018
Figure 74: Seasonal Influenza Vaccine Market, Singapore, Number of Doses Forecast by Age Group (‘000), 2011–2018
Figure 75: Seasonal Influenza Vaccine Market, Singapore, Market Share by Company (%), 2012
Figure 76: Seasonal Influenza Vaccine Market, Singapore, Drivers and Barriers, 2012
Figure 77: Seasonal Influenza Vaccine Market, Taiwan, Regulatory Authorities, 2011
Figure 78: Seasonal Influenza Vaccine Market, Taiwan, Drug Approval Process, 2011
Figure 79: Seasonal Influenza Vaccine Market, Taiwan, Revenue Forecast ($m), 2011–2018
Figure 80: Seasonal Influenza Vaccine Market, Taiwan, Vaccination Cost Forecast ($), 2011–2018
Figure 81: Seasonal Influenza Vaccine Market, Taiwan, Population Forecast by Age Group (million), 2011–2018
Figure 82: Seasonal Influenza Vaccine Market, Taiwan, Vaccinated Population Forecast by Age Group (%), 2011–2018
Figure 83: Seasonal Influenza Vaccine Market, Taiwan, Number of Doses Forecast by Age Group (million), 2011–2018
Figure 84: Seasonal Influenza Vaccine Market, Taiwan, Market Share by Company (%), 2012
Figure 85: Seasonal Influenza Vaccine Market, Taiwan, Drivers and Barriers, 2012
Figure 86: Seasonal Influenza Vaccine Market, APAC Region, Pipeline by Phase (%), 2012
Figure 87: Seasonal Influenza Vaccine Market, APAC Region, M&A Deals by Geography (%), 2007–2012
Figure 88: Seasonal Influenza Vaccine Market, APAC Region, Licensing Agreements by Geography, (%), 2007–2012
Figure 89: GBI Research Market Forecasting Model

- Sanofi Pasteur
- GlaxoSmithKline Biologicals
- Abbott Laboratories (Solvay Pharmaceuticals)
- CSL Biotherapies
- Novartis Vaccines
- Crucell N.V. (Berna Biotech)

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos